Adicet Bio Inc


Prices are adjusted according to historical splits.

Adicet Bio Inc Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
$331.24 million
Book Value:
Revenue TTM:
$30.46 million
Operating Margin TTM:
Gross Profit TTM:
$9.73 million
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

Adicet Bio Inc had its IPO on 2018-01-26 under the ticker symbol ACET.

The company operates in the Healthcare sector and Biotechnology industry. Adicet Bio Inc has a staff strength of 86 employees.

Stock update

Shares of Adicet Bio Inc opened at $7.62 at the start of the last trading session i.e. 2023-03-19.

The stocks traded within a range of $7.29 - $7.67, and closed at $7.43.

This is a -3.63% slip from the previous day's closing price.

A total volume of 3,544,200 shares were traded at the close of the day’s session.

In the last one week, shares of Adicet Bio Inc have slipped by -0.13%.

Adicet Bio Inc's Key Ratios

Adicet Bio Inc has a market cap of $331.24 million, indicating a price to book ratio of 2.3297 and a price to sales ratio of 13.9986.

In the last 12-months Adicet Bio Inc’s revenue was $30.46 million with a gross profit of $9.73 million and an EBITDA of $-55627000. The EBITDA ratio measures Adicet Bio Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Adicet Bio Inc’s operating margin was -188.81% while its return on assets stood at -11.76% with a return of equity of -20.84%.

In Q3, Adicet Bio Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 1.1%.

Adicet Bio Inc’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at $-1.44 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0.82. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Adicet Bio Inc’s profitability.

Adicet Bio Inc stock is trading at a EV to sales ratio of 15.7292 and a EV to EBITDA ratio of -8.9083. Its price to sales ratio in the trailing 12-months stood at 13.9986.

Adicet Bio Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$354.30 million
Total Liabilities
$17.22 million
Operating Cash Flow
Capital Expenditure
$4.81 million
Dividend Payout Ratio

Adicet Bio Inc ended 2023 with $354.30 million in total assets and $0 in total liabilities. Its intangible assets were valued at $354.30 million while shareholder equity stood at $317.66 million.

Adicet Bio Inc ended 2023 with $0 in deferred long-term liabilities, $17.22 million in other current liabilities, 4000.00 in common stock, $-208240000.00 in retained earnings and $19.46 million in goodwill. Its cash balance stood at $282.68 million and cash and short-term investments were $282.68 million. The company’s total short-term debt was $2,409,000 while long-term debt stood at $0.

Adicet Bio Inc’s total current assets stands at $285.74 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $29000.00 compared to accounts payable of $4.57 million and inventory worth $0.

In 2023, Adicet Bio Inc's operating cash flow was $-4811000.00 while its capital expenditure stood at $4.81 million.

Comparatively, Adicet Bio Inc paid $0 in dividends in 2023.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

Adicet Bio Inc stock is currently trading at $7.43 per share. It touched a 52-week high of $21.87 and a 52-week low of $21.87. Analysts tracking the stock have a 12-month average target price of $27.36.

Its 50-day moving average was $8.19 and 200-day moving average was $13.43 The short ratio stood at 8.97 indicating a short percent outstanding of 0%.

Around 482.8% of the company’s stock are held by insiders while 10117.9% are held by institutions.

Frequently Asked Questions About Adicet Bio Inc

The stock symbol (also called stock or share ticker) of Adicet Bio Inc is ACET

The IPO of Adicet Bio Inc took place on 2018-01-26

Similar Industry Stocks (Biotechnology)

Last Price

Most Active

Last Price

Top Gainers

Last Price

Top Losers

Last Price


Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin’s lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is based in Boston, Massachusetts.


200 Clarendon Street, Boston, MA, United States, 02116